After COVID-19 Vaccine Setbacks, GSK Expands Vir Antibody Pact

Companies’ Respiratory Deal Aims Beyond Coronavirus

3D_Coronavirus
GSK is expanding its pact with Vir after setbacks on COVID-19 vaccines. • Source: Shutterstock

More from R&D

More from Scrip